Results 81 to 90 of about 31,480,937 (161)

Characterisation of HLA-specific antibodies [PDF]

A successful kidney transplant is the best treatment for established renal failure, yet around 300 patients per annum are denied transplants because they have antibodies, most notably directed against donor HLA or ABO in their blood, which have the ...
Lowe, David Philip
core  

HLA high performance and real-time simulation studies with CERTI [PDF]

, 2011
Our work takes place in the context of the HLA standard and its application in real-time systems context. Indeed, current HLA standard is inadequate for taking into consideration the different constraints involved in real-time computer systems.
Adelantado, Martin, Noulard, Eric, Chaudron, Jean-Baptiste, Siron, Pierre   +3 more
core  

Identification of the Novel HLA-DQB1*06:432 Allele by Sequence-Based Typing

HLA-DQB1*06:432 differs from HLA-DQB1*06:09:01:01 by a nonsynonymous nucleotide substitution in codon 186, changing Valine to ...
John Jeongseok Yang, Heung-Bum Oh
core   +1 more source

HLA-E, -H, -G, -F and HFE relative location and distance from HLA-A on chromosome 6.

, 2016
HLA-E, -H, -G, -F and HFE relative location and distance from HLA-A on chromosome 6.
Julie Di Cristofaro (473988), Jacques Chiaroni (473993), Audrey Tous (3192987), Stéphane Buhler (149592), Virginia Ferreira (3192984), Céline René (10829), Jean-François Eliaou (273686), Federico Carlini (501365), Christophe Picard (501369)   +8 more
core   +1 more source

The Impact of HLA-E Polymorphisms in Graft-versus-Host Disease following HLA-E Matched Allogeneic Hematopoietic Stem Cell Transplantation

Iranian Journal of Allergy, Asthma and Immunology, 2012
The  non-classical MHC  class-I mainly involves in the  regulation of  innate  immune responses where HLA-E  plays a significant role in the cell identification by natural killer cells. HLA-E is a main regulatory ligand for natural killer cells and given
Ehteramolsadat Hosseini, Anthony P. Schwarer, Mehran Ghasemzadeh   +2 more
doaj  

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies

Frontiers in Immunology
Advances in immunotherapy rely on targeting novel cell surface antigens, including therapeutically relevant peptide fragments presented by HLA molecules, collectively known as the actionable immunopeptidome.
Maya Weitzen, Mohammad Shahbazy, Saketh Kapoor, Etienne Caron, Etienne Caron   +4 more
doaj   +1 more source

Recognition of the new HLA-DQB1*06 variant, HLA-DQB1*06:03:41, in a Russian individual

, 2021
One nucleotide substitution in codon 174 of HLA-DQB1*06:03:01:01 results in a novel allele, HLA-DQB1*06:03 ...
Shagimardanova E., Leksina Y., Ananeva A., Gusev O.   +3 more
core  

The novel HLA-DQA1*03:75 allele identified in a Korean kidney donor

HLA-DQA1*03:75 differs from HLA-DQA1*03:02:01:01 by a single non-synonymous nucleotide substitution in exon ...
John Jeongseok Yang, Heung-Bum Oh, Si-Hwan Kim   +2 more
core   +1 more source

Genomic full-length sequence of the novel HLA-B*40:540N allele

The coding sequence of HLA-B*40:540N differs from HLA-B*40:02:01:01 by a non-synonymous nucleotide substitution in exon ...
John Jeongseok Yang, Heung-Bum Oh
core   +1 more source

Polymorphism of HLA and Susceptibility of Breast Cancer

Frontiers in Bioscience-Landmark
Breast cancer (BC) is the second most common malignancy in the world. Numerous studies have demonstrated the association between human leukocyte antigen (HLA) and cancer. The occurrence and development of BC are closely linked to genetic factors.
Sara Aboulaghras, Asaad Khalid, Hafiz A. Makeen, Hassan A. Alhazmi, Mohammed Albratty, Syam Mohan, Bey Hing Goh, Chien Ing Yeo, Yee Seng Tan, Abdelhakim Bouyahya   +9 more
doaj   +1 more source